drugset / Trial / NCT01151579

Effect of Nebulized Bronchodilators on Heart Rate

NCT01151579

Phase 4 Completed 89 enrolled Fahim Khorfan, MD Ascension Health · collab
RandomizedCrossoverSingle-blindSupportive care

Summary

The purpose of the study is to determine adverse events rates of nebulized albuterol versus levalbuterol among adult critically ill patients and determine if a differential exists in adverse events between the two drugs.

Timeline

Start
2008-12
Primary completion
2009-11
Completion
2009-11

Drugs

EvaluationDrugModalityDoseRoute
Comparator Levalbuterol Other / unclassified 0.63 mg Inhaled
Comparator Levalbuterol Other / unclassified 1.25 mg Inhaled
Comparator Salbutamol Unknown 2.5 mg Inhaled